Empagliflozin Efficacy and Mineralocorticoid Receptor Antagonists in Patients With HF
Researchers sought to compare the effect of empagliflozin in patients that do vs patients that do not take mineralocorticoid receptor antagonists for HFpEF.
Researchers sought to compare the effect of empagliflozin in patients that do vs patients that do not take mineralocorticoid receptor antagonists for HFpEF.
For patients surviving acute myocardial infarction (AMI), the 10-year mortality and recurrence rates have decreased over the last decades.
Investigators evaluated the efficacy of sodium-glucose cotransporter-2 inhibitors for patients with different types of heart failure.
A study was conducted to determine the prognostic value of hyponatremia and its effect on the effectiveness of dapagliflozin in patients hospitalized for HFrEF.
Nitrosamine impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.
Investigators examined the relationship among nutritional status, hyponatremia, and risk for morality in patients with heart failure.
A study was conducted to examine the relationship between stages of early heart failure and risk for future cardiovascular and non-CV events.
A pilot study was conducted to identify distinct phenogroups of HFpEF and determine if these phenogroups are associated with specific blood proteome profiles.
Infertility is significantly associated with later incident heart failure.
The placebo-controlled, event-driven DELIVER study included 6263 patients.